GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

I attended my high school reunion and had no anxiety about appearance,” Sarah gushed. “My new problem was graciously ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

As 2025 ushers in a new era of weight loss resolutions, many Americans are abandoning traditional gym-first approaches in ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Wegovy, the weight loss medication you can only get with a prescription from a licensed healthcare professional, may intrigue you. Here’s who is eligible and what to expect at your initial ...